Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study

1. Schmid, P.
2. Lipatov, O.
3. Im, S.-A.
4. Goncalves, A.
5. Muñoz-Couselo, E.
6. Lee, K.S.
7. Tamura, K.
8. Testa, L.
9. Witzel, I.
10. Ohtani, S.
11. Turner, N.
12. Zambelli, S.
13. Harbeck, N.
14. Andre, F.
15. Dent, R.
16. Mejia, J.A.
17. Zhou, X.
18. Haiderali, A.
19. Nguyen, A.M.
20. Cortes, J.
21. Winer, E.P.